17:05:00·11d

Annals of Internal Medicine Publishes 12-Month Results from LivaNova's OSPREY Clinical Study for Obstructive Sleep Apnea

ByQuantisnow·Wall Street's wire, on your screen.

Health Care

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Open live feed

Companies

LIVN
LivaNova PLC
Health Care

Recent analyst ratings

Dec 19UpdateKeyBanc Capital Markets$81.00
Oct 1UpdateGoldman$55.00
May 20UpdateWolfe Research$60.00
Feb 26UpdateWolfe Research-
Oct 4UpdateGoldman$65.00
Sep 17UpdateRobert W. Baird$66.00

SEC1d
Amendment: SEC Form SCHEDULE 13G/A filed by LivaNova PLC
SEC3d
SEC Form DEFA14A filed by LivaNova PLC
SEC3d
SEC Form DEF 14A filed by LivaNova PLC
INSIDER30d
SEC Form 4 filed by Tezel Ahmet
INSIDER30d
SEC Form 4 filed by Poletti Franco
INSIDER30d
SEC Form 4 filed by Makatsaria Vladimir
INSIDER30d
SEC Form 4 filed by Shvartsburg Alex
INSIDER30d
SEC Form 4 filed by Bolton Stephanie